Xiucheng Pan

716 total citations
24 papers, 459 citations indexed

About

Xiucheng Pan is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Xiucheng Pan has authored 24 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Hepatology and 7 papers in Immunology. Recurrent topics in Xiucheng Pan's work include Hepatitis B Virus Studies (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (7 papers). Xiucheng Pan is often cited by papers focused on Hepatitis B Virus Studies (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (7 papers). Xiucheng Pan collaborates with scholars based in China, Japan and Netherlands. Xiucheng Pan's co-authors include Juan Fu, Hongjuan You, Fanyun Kong, Renxian Tang, Ji Fang, Xuebing Yan, Bing Gu, Liang Wang, Mingjia Dai and Yan Liu and has published in prestigious journals such as Frontiers in Immunology, Emerging infectious diseases and Medicine.

In The Last Decade

Xiucheng Pan

23 papers receiving 452 citations

Peers

Xiucheng Pan

EPIDE

IMMUN

HEPAT

Lai Wei China

Yuhui Fan China

Sujit Mukherjee United Kingdom

Yixiang Zheng China

Hongyu Jia China

Xingfei Pan China

Jiansheng Zhu China

Yali Xiong China

Lei Yuan China

Guiwen Guan China

Lai Wei China

Xiucheng Pan

207 ×1.4

EPIDE

153 ×1.3

IMMUN

114 ×1.1

168 ×1.8

22 ×0.3

HEPAT

Citations per year, relative to Xiucheng Pan Xiucheng Pan (= 1×) peers Lai Wei

Countries citing papers authored by Xiucheng Pan

Since Specialization

Citations

This map shows the geographic impact of Xiucheng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiucheng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiucheng Pan more than expected).

Fields of papers citing papers by Xiucheng Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiucheng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiucheng Pan. The network helps show where Xiucheng Pan may publish in the future.

Co-authorship network of co-authors of Xiucheng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiucheng Pan. A scholar is included among the top collaborators of Xiucheng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiucheng Pan. Xiucheng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Fanyun, Yujie Zhong, Yuxin Wang, et al.. (2025). HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. Hepatology Communications. 9(6).

Yang, Guangde, et al.. (2024). Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First‐Time HBV‐Related Decompensated Cirrhosis. Journal of Viral Hepatitis. 32(4). e14029–e14029. 1 indexed citations

Shen, Jiaming, Xia Wang, Guangde Yang, et al.. (2024). Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors. Journal of Hepatocellular Carcinoma. Volume 11. 207–217. 4 indexed citations

Wang, Ningning, et al.. (2024). The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 1311–1321. 2 indexed citations

You, Hongjuan, Xing Wang, Fulong Zhang, et al.. (2023). Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Communication and Signaling. 21(1). 70–70. 27 indexed citations

Guo, Hongbo, Dan Liu, Kuan Liu, et al.. (2023). Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions. Virologica Sinica. 39(1). 123–133. 5 indexed citations

Shen, Jiaming, Xia Wang, Ningning Wang, et al.. (2023). HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors. Frontiers in Cellular and Infection Microbiology. 13. 1179689–1179689. 10 indexed citations

Shen, Jiaming, Xia Wang, Guangde Yang, et al.. (2023). Development and validation of a nomogram to predict recompensation in HBV-related cirrhosis with ascites as the single first decompensating event. Scandinavian Journal of Gastroenterology. 58(8). 915–922. 6 indexed citations

Fu, Juan, et al.. (2023). Risk factors of low‐level viremia in chronic hepatitis B patients receiving Entecavir monotherapy: a retrospective cohort study. Journal of Gastroenterology and Hepatology. 39(1). 180–184. 6 indexed citations

10.

You, Hongjuan, Xing Wang, Fulong Zhang, et al.. (2022). The emerging role of DEAD/H-box helicases in hepatitis B virus infection. Frontiers in Cellular and Infection Microbiology. 12. 1062553–1062553. 4 indexed citations

11.

You, Hongjuan, Fulong Zhang, Wei Hu, et al.. (2022). Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection. Frontiers in Immunology. 13. 829923–829923. 22 indexed citations

12.

Li, Rongqing, Xueqin Li, Jie Zhao, et al.. (2021). Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation. Theranostics. 12(2). 976–998. 97 indexed citations

13.

Kong, Fanyun, Qi Li, Fulong Zhang, et al.. (2021). Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection. Frontiers in Medicine. 8. 751516–751516. 13 indexed citations

14.

Kong, Fanyun, Fulong Zhang, Xiangye Liu, et al.. (2021). Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target. Cell Communication and Signaling. 19(1). 82–82. 21 indexed citations

15.

Li, Chan, et al.. (2019). Tim‐3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B. Scandinavian Journal of Immunology. 89(5). e12755–e12755. 12 indexed citations

16.

Wang, Xia, Zhi‐Qiang Xu, Juan Fu, et al.. (2018). Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon. Medicine. 97(23). e10891–e10891. 3 indexed citations

17.

Wu, Qingyun, Ziguang Yan, Wenjun Mou, et al.. (2013). The Protection and Therapy Effects of Bortezomib in Murine Acute Graft-Versus-Host Disease. Transplantation Proceedings. 45(6). 2527–2535. 8 indexed citations

18.

Pan, Xiucheng, et al.. (2012). Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma. Oncology Letters. 5(1). 90–96. 25 indexed citations

19.

Xu, Kailin, et al.. (2008). Prophylaxis of Graft-Versus-Host Disease by Lentiviral-Mediated Expression of Herpes Simplex Virus-Thymidine Kinase and Ganciclovir Treatment. Transplantation Proceedings. 40(8). 2665–2669. 2 indexed citations

20.

Pan, Xiucheng, Fan Yang, & Ming Chen. (2008). [The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B].. PubMed. 16(12). 885–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact